newsfilter
← Latest News
ACCESS Newswire·

Jaguar Health Expands Neonorm Franchise with Introduction of Neonorm Dog for Companion Animal Gut Health

  • Jaguar Health, Inc. announced the planned launch of Neonorm Dog, an extension of its Neonorm franchise for companion animals.
  • Neonorm Dog is a non-prescription, plant-based product designed to support normal stool formation, gut hydration, & bowel health in dogs.
  • The new product builds on the existing Neonorm franchise which includes Neonorm Foal & Neonorm Calf, both utilizing standardized botanical extracts from the Croton lechleri tree.
  • Jaguar's animal health strategy focuses on gastrointestinal products for companion & production animals, including the conditionally approved prescription drug Canalevia-CA1 for chemotherapy-induced diarrhea in dogs.
  • The company expects Neonorm Dog to broaden its commercial footprint in the companion animal market & increase awareness of its plant-based, non-antibiotic options among pet owners, veterinarians, & retailers.
  • Neonorm Dog is expected to be available through select online & animal health retail channels once final packaging, labeling, & commercial preparations are complete.
  • Neonorm products are not intended to diagnose, treat, cure, or prevent disease, nor are they a substitute for veterinary care.